PAM
SGMO

Premier Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Premier Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,000
Closed -$30K – 106
2016
Q4 		$30K Sell
10,000
-4,000
-29% -$14.6K 0.01% 102
2016
Q3 		$64K Buy
14,000
+2,000
+17% +$10.2K 0.02% 97
2016
Q2 		$69K Hold
12,000
– – 0.02% 93
2016
Q1 		$72K Hold
12,000
– – 0.02% 89
2015
Q4 		$109K Hold
12,000
– – 0.03% 87
2015
Q3 		$67K Buy
+12,000
New +$99K 0.02% 91

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

Premier Asset Management's SGMO Position: Q1 2017 in Review

Premier Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2017, closing a stake of 10,000 shares — an estimated $30K sold.

Premier Asset Management first reported a position in SGMO in Q3 2015 and held it in 6 quarters. The position peaked at $109K in Q4 2015. 118 funds tracked by Wall St. Rank hold SGMO as of Q1 2017.

  • Premier Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2017 after selling out during the quarter.
  • Premier Asset Management sold 10,000 SANGAMO THERAPEUTICS INC shares in Q1 2017, an estimated $30K.
  • Premier Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2015 and held it in 6 quarters.
  • Premier Asset Management's SANGAMO THERAPEUTICS INC position peaked at $109K in Q4 2015.
  • 118 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2017.

Based on Premier Asset Management's 13F filing for Q1 2017, filed 9 May 2017.